Please ensure Javascript is enabled for purposes of website accessibility

Why HEXO Shares Got Higher on Thursday

By Eric Volkman – Jul 9, 2020 at 5:56PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company is rolling out a set of medical marijuana products in a market far overseas.

What happened

HEXO (HEXO 7.23%) is taking a significant step into a new market abroad, and investors are rewarding it -- its stock closed nearly 6% higher on Thursday.

Earlier in the day the marijuana company announced it has launched a set of medical marijuana products in Israel. These will be distributed and sold in collaboration with a local company, Breath of Life International, under a 24-month contract.

Israeli flag superimposed over marijuana buds.

Image source: Getty Images.

So what

HEXO's press release pictured four products, all of which are comprised of marijuana flower. They are sold in packages with labeling in both Hebrew and English.

Medical cannabis sale and use is legal in Israel, although under strict parameters. Recreational marijuana is illegal, although it was recently decriminalized.

HEXO products for the Israel market.

Image source: HEXO.

HEXO said the Israel rollout "is a testament to the continued work we are doing to expand our international footprint and find new markets for our award-winning products."

Teaming with Breath of Life International should spread HEXO's goods widely throughout the country. HEXO says company has a distribution network that includes Super-Pharm -- the nation's largest pharmacy chain at 258 stores.

Now what

News of a new international market is always welcome in the ever-challenging marijuana industry. But the Israeli medical cannabis space is fairly small and limited, and HEXO continues to struggle with profitability. This deal alone won't turn around the company's fortunes.

 

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

HEXO Stock Quote
HEXO
HEXO
$0.19 (7.23%) $0.01

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
331%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/05/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.